
	Search		Keep Me Updated		Tell a Friend		Add to My Favorites

PRELIMINARY SCIENTIFIC PROGRAM

Section: Ocular Inflammation and Infection

Chairpersons: R. Neumann Israel,
S.C. Foster, USA

Systemic Drugs

Back To Section List

Panel:

S.C. Foster, USA
S. Lightman, UK
R. Neumann, Israel

Systemic Steroids
W. Ayliffe, UK

Cyclosporin A and Tacrolimus
A. Okada, Japan

Alkylating Agents
M.T. Sainz de la Maza, Spain

Rituxan, Tysabri and Future Biologics
J.T. Rosenbaum, USA

Who are Coming to the Clinics for Ocular Inflammatory Diseases?
Q.D. Nguyan, USA

Gap Analysis: The Unmet Medical Need (A Call for the Companies)
S.C. Foster, USA

Systemic Anti-Metabolites

Back To Section List

Chairperson: S. Lightman, UK

Systemic Methotrexate for Uveitis
J.T. Rosenbaum, USA

Mycophenolate Mofetil in Uveitis
S. Lightman, UK

Intraocular Anti-Metabolites - Intraocular Methotrexate in Uveitis
S. Taylor, UK

Topical Anti-Metabolites - 5FU and MMC in the Management of Uveitic Glaucoma
P. McCluskey, Australia

Infection

Back To Section List

Chairperson: I. Barequet, Israel

In Vitro and In Vivo Susceptibility - Antibiotic Interaction
R.P. Kowalski, USA

New Developments of Antiviral Agents for Adenovirus
E. Romanowski, USA

Resistance to Fluoroquinolones
C.-K. Joo, South Korea

Tracking Resistance in the USA Today (TRUST)
P.A. Asbell, USA

P. aeruginosa LasA Protease as a Therapeutic Agent in S. Aureus Ocular Infections
I. Barequet, Israel